edward neuwelt
机构: neurosurgery and neurology professor oregon health sciences university
每年引用次数
引用次数
引用: 29,763
H-指数: 88
I10-指数 : 286
出版物: 644
Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.
S. Roman-Goldstein , E. A. Neuwelt , G. Sexton , P. A. Barnett
American Journal of Pathology 146 ( 2) 436 -449
27
1995
Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease).
E. A. Neuwelt , L. L. Muldoon , M. A. Pagel , D. L. Weiss
American Journal of Pathology 144 ( 5) 1109 -1118
102
1994
Diffuse microglial proliferation after global ischemia in a patient with aplastic bone marrow.
J. H. Garcia , H. Mena , E. A. Neuwelt
Acta Neuropathologica 43 ( 3) 259 -262
6
1978
Elevated CSF gamma globulins with cerebral 'glioma'
K. Rao , J. H. Garcia , T. Ducker , O. Kolar
Surgical Neurology 8 ( 2) 107 -110
6
1977
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain
E. A. Neuwelt , X. O. Breakefield , R. A. Kroll , L. L. Muldoon
American Journal of Pathology 147 ( 6) 1840 -1851
115
1995
The importance of melatonin and tumor markers in pineal tumors.
E. A. Neuwelt , B. Mickey , A. J. Lewy
Journal of Neural Transmission-supplement 21 397 -413
11
1986
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
E. A. Neuwelt , E. P. Frenkel , S. E. Lewis , P. A. Barnett
Cancer treatment reports 65 39 -43
52
1981
Lipid nanoparticles for theranostic applications
Aurelie Marie Madeleine Schoubben , Maurizio Ricci , Paolo Blasi , Barbara Albertini
2014 Blood Brain Barrier Meeting
2014
Erratum: "The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway" Journal of Pharmacology and Experimental Therapeutics (2005) 312 (424-431)
J. Y. Wu , L. L. Muldoon , E. A. Neuwelt
Journal of Pharmacology and Experimental Therapeutics 317 ( 1)
49
2006
Delivery of therapeutic levels of methotrexate to the brain after reversible disruption of the blood brain barrier
E. A. Neuwelt , S. Hill , S. Rapoport
Proceedings of the American Association for Cancer Research 20
5
1979
Neurotoxicity of adriamycin infusion following osmotic blood brain barrier
E. A. Neuwelt , M. R. Glasberg , E. P. Frenkel
Journal of Neuropathology and Experimental Neurology 40 ( 3)
1981
Initial clinical studies of chemotherapy delivery to brain tumor patients after osmotic blood brain barrier modification
E. A. Neuwelt , J. T. Diehl , E. P. Frenkel , S. A. Hill
Proceedings of the American Association for Cancer Research 22
1
1981
Subarachnoid lymphocyte infusions: toxicity, kinetics and clinical potential
D. Doherty , E. A. Neuwelt , K. Clark
Proceedings of the American Association for Cancer Research 18
1977
Chemotherapy and monoclonal antibody delivery to malignant brain tumors: The role of blood-brain barrier modification
P. A. Barnett , E. A. Neuwelt , S. A. Dahlborg
Fernstrom Foundation Series 14 187 -196
1990
The effects of osmotic modification of the blood-brain barrier and adrenal steroid administration on methotrexate delivery to rodent gliomas
E. A. Neuwelt , D. Bigner , E. Frenkel , P. Barnett
Neurosurgery 9 ( 4) 471 -472
1981
Successful use of chemotherapy after osmotic blood-brain disruption in the treatment of microgliomas
E. A. Neuwelt , Eugene P Frenkel , S. Hill , J. Diehl
Annals of Neurology 12 ( 1)
1982
Immune responses in patients with brain tumors: Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity
K. Kikuchi , S. Hill , E. A. Neuwelt
Proceedings of the American Association for Cancer Research 23
1982
In vitro and in vivo characterization of lipid nanoparticles for brain drug targeting
Carlo Cirotto , Maurizio Ricci , Paolo Blasi , Lanfranco Barberini
1
2011
Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma
L. C. Rosenbaum , E. A. Neuwelt , H. H. Van Tol , Y. P. Loh
Proceedings of the National Academy of Sciences of the United States of America 87 ( 24) 9928 -9932
27
1990
The paradoxical effect of targeted antivascular agents in the therapy of CNS malignancies
E. A. Neuwelt , E. Frenkel
Journal of Clinical Oncology 27 2013 -2013
2009